According to Singh et al.'s study, immunohistochemical (IHC) expression of PBK/TOPK (P < 0.001) is significantly related to MIBC grade, and the protein is specific for human BC, suggesting that it might be used as a potential target for the development of cancer immunotherapy and diagnostic biomarkers [47]. This evidence concerns the gene PBK and breast cancer.